R104K (p.Arg104Lys) variant of TNXB (Tenascin-X)
R104K (p.Arg104Lys) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes structural context.
R104K (p.Arg104Lys) variant details
- p.Arg104Lys
- NCI-TCGA Cosmic COSV6447
- NCI-TCGA Cosmic COSV6448
- cosmic curated COSV64489
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.269
- ESM-1b 0.00
- AlphaMissense 0.08
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available